SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-010916
Filing Date
2022-02-17
Accepted
2022-02-17 17:36:26
Documents
2
Period of Report
2022-02-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4372
2 POA DOCUMENT poa.txt EX-24 2014
  Complete submission text file 0001209191-22-010916.txt   7825
Mailing Address C/O TENAYA THERAPEUTICS, INC. 171 OYSTER POINT BOULEVARD, 5TH FLR. SOUTH SAN FRANCISCO CA 94080
Business Address
Hoey Timothy (Reporting) CIK: 0001553333 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40656 | Film No.: 22649671

Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Issuer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)